Henry Flanner
Nessuna posizione attualmente
Profilo
Henry Flanner worked as a Senior Director-Pharmaceutical Research at Middlebrook Pharmaceuticals, Inc. from 2003 to 2007.
He also worked as a Director-Drug Delivery Sciences at Shire Laboratories, Inc. and as a Vice President-Technical Operations at GlycoMimetics, Inc. Mr. Flanner received a graduate degree from The Johns Hopkins University and an undergraduate degree from the University of South Carolina.
Precedenti posizioni note di Henry Flanner
Società | Posizione | Fine |
---|---|---|
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | Corporate Officer/Principal | 01/10/2007 |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | Corporate Officer/Principal | - |
GLYCOMIMETICS, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Henry Flanner
The Johns Hopkins University | Graduate Degree |
University of South Carolina | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
GLYCOMIMETICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | Health Technology |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | Commercial Services |
- Borsa valori
- Insiders
- Henry Flanner